テノフォビルアラフェナミドフマル酸塩錠剤のグローバル市場展望 2023年-2029年：先発医薬品、ジェネリック医薬品

• 英文タイトル：Tenofovir Alafenamide Fumarate Tablets Market, Global Outlook and Forecast 2023-2029

• レポートコード：MMG23DC14487 • 出版社/出版日：Market Monitor Global / 2023年12月 ※2025年版があります。お問い合わせください。 • レポート形態：英語、PDF、70ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医薬品

• 販売価格（消費税別）

Single User（1名様閲覧用）	￥471,250 (USD3,250)	▷ お問い合わせ
Multi User（20名様閲覧用）	￥612,625 (USD4,225)	▷ お問い合わせ
Enterprise User（閲覧人数制限なし）	￥706,875 (USD4,875)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

当調査レポートは次の情報を含め、世界のテノフォビルアラフェナミドフマル酸塩錠剤市場規模と予測を収録しています。・世界のテノフォビルアラフェナミドフマル酸塩錠剤市場：売上、2018年-2023年、2024年-2029年 ・世界のテノフォビルアラフェナミドフマル酸塩錠剤市場：販売量、2018年-2023年、2024年-2029年 ・世界のトップ5企業、2022年 世界のテノフォビルアラフェナミドフマル酸塩錠剤市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「先発医薬品」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。 テノフォビルアラフェナミドフマル酸塩錠剤のグローバル主要企業は、CSPC OUYI Pharmaceutical Co., Ltd.、 Gilead Sciences, Inc.、 Yichang Humanwell Pharmaceutical Co., Ltd.、 Shandong Loncom Pharmaceutical Co., Ltd、 Reyoung Pharmaceutical Co., Ltd.、 Suzhou Homesun Pharmaceutical Co.,Ltd.、 Hunan Mingrui Pharmaceutical Co., Ltd.、 DESANO、 Patheon Inc.、 Suzhou Thery Pharmaceutical Inc.、 Chengdu Easton Biopharmaceuticals Co.,Ltd.などです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。 MARKET MONITOR GLOBAL（MMG）は、テノフォビルアラフェナミドフマル酸塩錠剤のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。 【セグメント別市場分析】 世界のテノフォビルアラフェナミドフマル酸塩錠剤市場：タイプ別、2018年-2023年、2024年-2029年 世界のテノフォビルアラフェナミドフマル酸塩錠剤市場：タイプ別市場シェア、2022年 ・先発医薬品、ジェネリック医薬品 世界のテノフォビルアラフェナミドフマル酸塩錠剤市場：用途別、2018年-2023年、2024年-2029年 世界のテノフォビルアラフェナミドフマル酸塩錠剤市場：用途別市場シェア、2022年 ・病院、診療所、その他 世界のテノフォビルアラフェナミドフマル酸塩錠剤市場：地域・国別、2018年-2023年、2024年-2029年 世界のテノフォビルアラフェナミドフマル酸塩錠剤市場：地域別市場シェア、2022年 ・北米：アメリカ、カナダ、メキシコ ・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア ・アジア：中国、日本、韓国、東南アジア、インド ・南米：ブラジル、アルゼンチン ・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE 【競合分析】 また、当レポートは主要な市場参加者の分析を提供します。 ・主要企業におけるテノフォビルアラフェナミドフマル酸塩錠剤のグローバル売上、2018年-2023年 ・主要企業におけるテノフォビルアラフェナミドフマル酸塩錠剤のグローバル売上シェア、2022年 ・主要企業におけるテノフォビルアラフェナミドフマル酸塩錠剤のグローバル販売量、2018年-2023年 ・主要企業におけるテノフォビルアラフェナミドフマル酸塩錠剤のグローバル販売量シェア、2022年 さらに、当レポートは主要企業のプロファイルを提示します。 CSPC OUYI Pharmaceutical Co., Ltd.、 Gilead Sciences, Inc.、 Yichang Humanwell Pharmaceutical Co., Ltd.、 Shandong Loncom Pharmaceutical Co., Ltd、 Reyoung Pharmaceutical Co., Ltd.、 Suzhou Homesun Pharmaceutical Co.,Ltd.、 Hunan Mingrui Pharmaceutical Co., Ltd.、 DESANO、 Patheon Inc.、 Suzhou Thery Pharmaceutical Inc.、 Chengdu Easton Biopharmaceuticals Co.,Ltd. ************************************************************* ・調査・分析レポートの概要 テノフォビルアラフェナミドフマル酸塩錠剤市場の定義 市場セグメント 世界のテノフォビルアラフェナミドフマル酸塩錠剤市場概要 当レポートの特徴・ベネフィット 調査手法と情報源 ・世界のテノフォビルアラフェナミドフマル酸塩錠剤市場規模 世界のテノフォビルアラフェナミドフマル酸塩錠剤市場規模：2022年 VS 2029年 世界のテノフォビルアラフェナミドフマル酸塩錠剤市場規模と予測 2018年-2029年 ・競争状況 グローバルトップ企業 売上ベースでのグローバルトップ企業 企業別グローバルでのテノフォビルアラフェナミドフマル酸塩錠剤の売上 グローバルトップ3およびトップ5企業、2022年売上ベース グローバル企業のテノフォビルアラフェナミドフマル酸塩錠剤製品タイプ グローバルにおけるティア1、ティア2、ティア3企業 ・タイプ別市場分析 タイプ区分：先発医薬品、ジェネリック医薬品 テノフォビルアラフェナミドフマル酸塩錠剤のタイプ別グローバル売上・予測 ・用途別市場分析 用途区分：病院、診療所、その他 テノフォビルアラフェナミドフマル酸塩錠剤の用途別グローバル売上・予測 ・地域別市場分析 地域別テノフォビルアラフェナミドフマル酸塩錠剤市場規模 2022年と2029年 地域別テノフォビルアラフェナミドフマル酸塩錠剤売上・予測 北米市場：アメリカ、カナダ、メキシコ ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア アジア市場：中国、日本、韓国、東南アジア、インド 南米市場：ブラジル、アルゼンチン 中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE ・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど） CSPC OUYI Pharmaceutical Co., Ltd.、 Gilead Sciences, Inc.、 Yichang Humanwell Pharmaceutical Co., Ltd.、 Shandong Loncom Pharmaceutical Co., Ltd、 Reyoung Pharmaceutical Co., Ltd.、 Suzhou Homesun Pharmaceutical Co.,Ltd.、 Hunan Mingrui Pharmaceutical Co., Ltd.、 DESANO、 Patheon Inc.、 Suzhou Thery Pharmaceutical Inc.、 Chengdu Easton Biopharmaceuticals Co.,Ltd. ...

This research report provides a comprehensive analysis of the Tenofovir Alafenamide Fumarate Tablets market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Tenofovir Alafenamide Fumarate Tablets market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Tenofovir Alafenamide Fumarate Tablets, challenges faced by the industry, and potential opportunities for market players.
The global Tenofovir Alafenamide Fumarate Tablets market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Tenofovir Alafenamide Fumarate Tablets market presents opportunities for various stakeholders, including Hospital, Clinic. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Tenofovir Alafenamide Fumarate Tablets market. Additionally, the growing consumer demand present avenues for market expansion.
The global Tenofovir Alafenamide Fumarate Tablets market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Key Features:
The research report on the Tenofovir Alafenamide Fumarate Tablets market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Tenofovir Alafenamide Fumarate Tablets market.
Market Overview: The report provides a comprehensive overview of the Tenofovir Alafenamide Fumarate Tablets market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., Original Drugs, Generic Drugs), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the Tenofovir Alafenamide Fumarate Tablets market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Tenofovir Alafenamide Fumarate Tablets market’s trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Tenofovir Alafenamide Fumarate Tablets market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the Tenofovir Alafenamide Fumarate Tablets market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the Tenofovir Alafenamide Fumarate Tablets market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Tenofovir Alafenamide Fumarate Tablets market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Tenofovir Alafenamide Fumarate Tablets, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Tenofovir Alafenamide Fumarate Tablets market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
Tenofovir Alafenamide Fumarate Tablets market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Original Drugs
Generic Drugs
Market segment by Application
Hospital
Clinic
Other
Global Tenofovir Alafenamide Fumarate Tablets Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Major players covered
CSPC OUYI Pharmaceutical Co., Ltd.
Gilead Sciences, Inc.
Yichang Humanwell Pharmaceutical Co., Ltd.
Shandong Loncom Pharmaceutical Co., Ltd
Reyoung Pharmaceutical Co., Ltd.
Suzhou Homesun Pharmaceutical Co.,Ltd.
Hunan Mingrui Pharmaceutical Co., Ltd.
DESANO
Patheon Inc.
Suzhou Thery Pharmaceutical Inc.
Chengdu Easton Biopharmaceuticals Co.,Ltd.
Outline of Major Chapters:
Chapter 1: Introduces the definition of Tenofovir Alafenamide Fumarate Tablets, market overview.
Chapter 2: Global Tenofovir Alafenamide Fumarate Tablets market size in revenue and volume.
Chapter 3: Detailed analysis of Tenofovir Alafenamide Fumarate Tablets manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Tenofovir Alafenamide Fumarate Tablets in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Tenofovir Alafenamide Fumarate Tablets capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

レポート目次

---

1 Introduction to Research & Analysis Reports
1.1 Tenofovir Alafenamide Fumarate Tablets Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Tenofovir Alafenamide Fumarate Tablets Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Tenofovir Alafenamide Fumarate Tablets Overall Market Size
2.1 Global Tenofovir Alafenamide Fumarate Tablets Market Size: 2022 VS 2029
2.2 Global Tenofovir Alafenamide Fumarate Tablets Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Tenofovir Alafenamide Fumarate Tablets Sales: 2018-2029
3 Company Landscape
3.1 Top Tenofovir Alafenamide Fumarate Tablets Players in Global Market
3.2 Top Global Tenofovir Alafenamide Fumarate Tablets Companies Ranked by Revenue
3.3 Global Tenofovir Alafenamide Fumarate Tablets Revenue by Companies
3.4 Global Tenofovir Alafenamide Fumarate Tablets Sales by Companies
3.5 Global Tenofovir Alafenamide Fumarate Tablets Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Tenofovir Alafenamide Fumarate Tablets Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Tenofovir Alafenamide Fumarate Tablets Product Type
3.8 Tier 1, Tier 2 and Tier 3 Tenofovir Alafenamide Fumarate Tablets Players in Global Market
3.8.1 List of Global Tier 1 Tenofovir Alafenamide Fumarate Tablets Companies
3.8.2 List of Global Tier 2 and Tier 3 Tenofovir Alafenamide Fumarate Tablets Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Tenofovir Alafenamide Fumarate Tablets Market Size Markets, 2022 & 2029
4.1.2 Original Drugs
4.1.3 Generic Drugs
4.2 By Type – Global Tenofovir Alafenamide Fumarate Tablets Revenue & Forecasts
4.2.1 By Type – Global Tenofovir Alafenamide Fumarate Tablets Revenue, 2018-2023
4.2.2 By Type – Global Tenofovir Alafenamide Fumarate Tablets Revenue, 2024-2029
4.2.3 By Type – Global Tenofovir Alafenamide Fumarate Tablets Revenue Market Share, 2018-2029
4.3 By Type – Global Tenofovir Alafenamide Fumarate Tablets Sales & Forecasts
4.3.1 By Type – Global Tenofovir Alafenamide Fumarate Tablets Sales, 2018-2023
4.3.2 By Type – Global Tenofovir Alafenamide Fumarate Tablets Sales, 2024-2029
4.3.3 By Type – Global Tenofovir Alafenamide Fumarate Tablets Sales Market Share, 2018-2029
4.4 By Type – Global Tenofovir Alafenamide Fumarate Tablets Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Tenofovir Alafenamide Fumarate Tablets Market Size, 2022 & 2029
5.1.2 Hospital
5.1.3 Clinic
5.1.4 Other
5.2 By Application – Global Tenofovir Alafenamide Fumarate Tablets Revenue & Forecasts
5.2.1 By Application – Global Tenofovir Alafenamide Fumarate Tablets Revenue, 2018-2023
5.2.2 By Application – Global Tenofovir Alafenamide Fumarate Tablets Revenue, 2024-2029
5.2.3 By Application – Global Tenofovir Alafenamide Fumarate Tablets Revenue Market Share, 2018-2029
5.3 By Application – Global Tenofovir Alafenamide Fumarate Tablets Sales & Forecasts
5.3.1 By Application – Global Tenofovir Alafenamide Fumarate Tablets Sales, 2018-2023
5.3.2 By Application – Global Tenofovir Alafenamide Fumarate Tablets Sales, 2024-2029
5.3.3 By Application – Global Tenofovir Alafenamide Fumarate Tablets Sales Market Share, 2018-2029
5.4 By Application – Global Tenofovir Alafenamide Fumarate Tablets Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Tenofovir Alafenamide Fumarate Tablets Market Size, 2022 & 2029
6.2 By Region – Global Tenofovir Alafenamide Fumarate Tablets Revenue & Forecasts
6.2.1 By Region – Global Tenofovir Alafenamide Fumarate Tablets Revenue, 2018-2023
6.2.2 By Region – Global Tenofovir Alafenamide Fumarate Tablets Revenue, 2024-2029
6.2.3 By Region – Global Tenofovir Alafenamide Fumarate Tablets Revenue Market Share, 2018-2029
6.3 By Region – Global Tenofovir Alafenamide Fumarate Tablets Sales & Forecasts
6.3.1 By Region – Global Tenofovir Alafenamide Fumarate Tablets Sales, 2018-2023
6.3.2 By Region – Global Tenofovir Alafenamide Fumarate Tablets Sales, 2024-2029
6.3.3 By Region – Global Tenofovir Alafenamide Fumarate Tablets Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Tenofovir Alafenamide Fumarate Tablets Revenue, 2018-2029
6.4.2 By Country – North America Tenofovir Alafenamide Fumarate Tablets Sales, 2018-2029
6.4.3 US Tenofovir Alafenamide Fumarate Tablets Market Size, 2018-2029
6.4.4 Canada Tenofovir Alafenamide Fumarate Tablets Market Size, 2018-2029
6.4.5 Mexico Tenofovir Alafenamide Fumarate Tablets Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Tenofovir Alafenamide Fumarate Tablets Revenue, 2018-2029
6.5.2 By Country – Europe Tenofovir Alafenamide Fumarate Tablets Sales, 2018-2029
6.5.3 Germany Tenofovir Alafenamide Fumarate Tablets Market Size, 2018-2029
6.5.4 France Tenofovir Alafenamide Fumarate Tablets Market Size, 2018-2029
6.5.5 U.K. Tenofovir Alafenamide Fumarate Tablets Market Size, 2018-2029
6.5.6 Italy Tenofovir Alafenamide Fumarate Tablets Market Size, 2018-2029
6.5.7 Russia Tenofovir Alafenamide Fumarate Tablets Market Size, 2018-2029
6.5.8 Nordic Countries Tenofovir Alafenamide Fumarate Tablets Market Size, 2018-2029
6.5.9 Benelux Tenofovir Alafenamide Fumarate Tablets Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Tenofovir Alafenamide Fumarate Tablets Revenue, 2018-2029
6.6.2 By Region – Asia Tenofovir Alafenamide Fumarate Tablets Sales, 2018-2029
6.6.3 China Tenofovir Alafenamide Fumarate Tablets Market Size, 2018-2029
6.6.4 Japan Tenofovir Alafenamide Fumarate Tablets Market Size, 2018-2029
6.6.5 South Korea Tenofovir Alafenamide Fumarate Tablets Market Size, 2018-2029
6.6.6 Southeast Asia Tenofovir Alafenamide Fumarate Tablets Market Size, 2018-2029
6.6.7 India Tenofovir Alafenamide Fumarate Tablets Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Tenofovir Alafenamide Fumarate Tablets Revenue, 2018-2029
6.7.2 By Country – South America Tenofovir Alafenamide Fumarate Tablets Sales, 2018-2029
6.7.3 Brazil Tenofovir Alafenamide Fumarate Tablets Market Size, 2018-2029
6.7.4 Argentina Tenofovir Alafenamide Fumarate Tablets Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Tenofovir Alafenamide Fumarate Tablets Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Tenofovir Alafenamide Fumarate Tablets Sales, 2018-2029
6.8.3 Turkey Tenofovir Alafenamide Fumarate Tablets Market Size, 2018-2029
6.8.4 Israel Tenofovir Alafenamide Fumarate Tablets Market Size, 2018-2029
6.8.5 Saudi Arabia Tenofovir Alafenamide Fumarate Tablets Market Size, 2018-2029
6.8.6 UAE Tenofovir Alafenamide Fumarate Tablets Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 CSPC OUYI Pharmaceutical Co., Ltd.
7.1.1 CSPC OUYI Pharmaceutical Co., Ltd. Company Summary
7.1.2 CSPC OUYI Pharmaceutical Co., Ltd. Business Overview
7.1.3 CSPC OUYI Pharmaceutical Co., Ltd. Tenofovir Alafenamide Fumarate Tablets Major Product Offerings
7.1.4 CSPC OUYI Pharmaceutical Co., Ltd. Tenofovir Alafenamide Fumarate Tablets Sales and Revenue in Global (2018-2023)
7.1.5 CSPC OUYI Pharmaceutical Co., Ltd. Key News & Latest Developments
7.2 Gilead Sciences, Inc.
7.2.1 Gilead Sciences, Inc. Company Summary
7.2.2 Gilead Sciences, Inc. Business Overview
7.2.3 Gilead Sciences, Inc. Tenofovir Alafenamide Fumarate Tablets Major Product Offerings
7.2.4 Gilead Sciences, Inc. Tenofovir Alafenamide Fumarate Tablets Sales and Revenue in Global (2018-2023)
7.2.5 Gilead Sciences, Inc. Key News & Latest Developments
7.3 Yichang Humanwell Pharmaceutical Co., Ltd.
7.3.1 Yichang Humanwell Pharmaceutical Co., Ltd. Company Summary
7.3.2 Yichang Humanwell Pharmaceutical Co., Ltd. Business Overview
7.3.3 Yichang Humanwell Pharmaceutical Co., Ltd. Tenofovir Alafenamide Fumarate Tablets Major Product Offerings
7.3.4 Yichang Humanwell Pharmaceutical Co., Ltd. Tenofovir Alafenamide Fumarate Tablets Sales and Revenue in Global (2018-2023)
7.3.5 Yichang Humanwell Pharmaceutical Co., Ltd. Key News & Latest Developments
7.4 Shandong Loncom Pharmaceutical Co., Ltd
7.4.1 Shandong Loncom Pharmaceutical Co., Ltd Company Summary
7.4.2 Shandong Loncom Pharmaceutical Co., Ltd Business Overview
7.4.3 Shandong Loncom Pharmaceutical Co., Ltd Tenofovir Alafenamide Fumarate Tablets Major Product Offerings
7.4.4 Shandong Loncom Pharmaceutical Co., Ltd Tenofovir Alafenamide Fumarate Tablets Sales and Revenue in Global (2018-2023)
7.4.5 Shandong Loncom Pharmaceutical Co., Ltd Key News & Latest Developments
7.5 Reyoung Pharmaceutical Co., Ltd.
7.5.1 Reyoung Pharmaceutical Co., Ltd. Company Summary
7.5.2 Reyoung Pharmaceutical Co., Ltd. Business Overview
7.5.3 Reyoung Pharmaceutical Co., Ltd. Tenofovir Alafenamide Fumarate Tablets Major Product Offerings
7.5.4 Reyoung Pharmaceutical Co., Ltd. Tenofovir Alafenamide Fumarate Tablets Sales and Revenue in Global (2018-2023)
7.5.5 Reyoung Pharmaceutical Co., Ltd. Key News & Latest Developments
7.6 Suzhou Homesun Pharmaceutical Co.,Ltd.
7.6.1 Suzhou Homesun Pharmaceutical Co.,Ltd. Company Summary
7.6.2 Suzhou Homesun Pharmaceutical Co.,Ltd. Business Overview
7.6.3 Suzhou Homesun Pharmaceutical Co.,Ltd. Tenofovir Alafenamide Fumarate Tablets Major Product Offerings
7.6.4 Suzhou Homesun Pharmaceutical Co.,Ltd. Tenofovir Alafenamide Fumarate Tablets Sales and Revenue in Global (2018-2023)
7.6.5 Suzhou Homesun Pharmaceutical Co.,Ltd. Key News & Latest Developments
7.7 Hunan Mingrui Pharmaceutical Co., Ltd.
7.7.1 Hunan Mingrui Pharmaceutical Co., Ltd. Company Summary
7.7.2 Hunan Mingrui Pharmaceutical Co., Ltd. Business Overview
7.7.3 Hunan Mingrui Pharmaceutical Co., Ltd. Tenofovir Alafenamide Fumarate Tablets Major Product Offerings
7.7.4 Hunan Mingrui Pharmaceutical Co., Ltd. Tenofovir Alafenamide Fumarate Tablets Sales and Revenue in Global (2018-2023)
7.7.5 Hunan Mingrui Pharmaceutical Co., Ltd. Key News & Latest Developments
7.8 DESANO
7.8.1 DESANO Company Summary
7.8.2 DESANO Business Overview
7.8.3 DESANO Tenofovir Alafenamide Fumarate Tablets Major Product Offerings
7.8.4 DESANO Tenofovir Alafenamide Fumarate Tablets Sales and Revenue in Global (2018-2023)
7.8.5 DESANO Key News & Latest Developments
7.9 Patheon Inc.
7.9.1 Patheon Inc. Company Summary
7.9.2 Patheon Inc. Business Overview
7.9.3 Patheon Inc. Tenofovir Alafenamide Fumarate Tablets Major Product Offerings
7.9.4 Patheon Inc. Tenofovir Alafenamide Fumarate Tablets Sales and Revenue in Global (2018-2023)
7.9.5 Patheon Inc. Key News & Latest Developments
7.10 Suzhou Thery Pharmaceutical Inc.
7.10.1 Suzhou Thery Pharmaceutical Inc. Company Summary
7.10.2 Suzhou Thery Pharmaceutical Inc. Business Overview
7.10.3 Suzhou Thery Pharmaceutical Inc. Tenofovir Alafenamide Fumarate Tablets Major Product Offerings
7.10.4 Suzhou Thery Pharmaceutical Inc. Tenofovir Alafenamide Fumarate Tablets Sales and Revenue in Global (2018-2023)
7.10.5 Suzhou Thery Pharmaceutical Inc. Key News & Latest Developments
7.11 Chengdu Easton Biopharmaceuticals Co.,Ltd.
7.11.1 Chengdu Easton Biopharmaceuticals Co.,Ltd. Company Summary
7.11.2 Chengdu Easton Biopharmaceuticals Co.,Ltd. Business Overview
7.11.3 Chengdu Easton Biopharmaceuticals Co.,Ltd. Tenofovir Alafenamide Fumarate Tablets Major Product Offerings
7.11.4 Chengdu Easton Biopharmaceuticals Co.,Ltd. Tenofovir Alafenamide Fumarate Tablets Sales and Revenue in Global (2018-2023)
7.11.5 Chengdu Easton Biopharmaceuticals Co.,Ltd. Key News & Latest Developments
8 Global Tenofovir Alafenamide Fumarate Tablets Production Capacity, Analysis
8.1 Global Tenofovir Alafenamide Fumarate Tablets Production Capacity, 2018-2029
8.2 Tenofovir Alafenamide Fumarate Tablets Production Capacity of Key Manufacturers in Global Market
8.3 Global Tenofovir Alafenamide Fumarate Tablets Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Tenofovir Alafenamide Fumarate Tablets Supply Chain Analysis
10.1 Tenofovir Alafenamide Fumarate Tablets Industry Value Chain
10.2 Tenofovir Alafenamide Fumarate Tablets Upstream Market
10.3 Tenofovir Alafenamide Fumarate Tablets Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Tenofovir Alafenamide Fumarate Tablets Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Tenofovir Alafenamide Fumarate Tablets in Global Market
Table 2. Top Tenofovir Alafenamide Fumarate Tablets Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Tenofovir Alafenamide Fumarate Tablets Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Tenofovir Alafenamide Fumarate Tablets Revenue Share by Companies, 2018-2023
Table 5. Global Tenofovir Alafenamide Fumarate Tablets Sales by Companies, (K Units), 2018-2023
Table 6. Global Tenofovir Alafenamide Fumarate Tablets Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Tenofovir Alafenamide Fumarate Tablets Price (2018-2023) & (US$/Unit)
Table 8. Global Manufacturers Tenofovir Alafenamide Fumarate Tablets Product Type
Table 9. List of Global Tier 1 Tenofovir Alafenamide Fumarate Tablets Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Tenofovir Alafenamide Fumarate Tablets Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Tenofovir Alafenamide Fumarate Tablets Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Tenofovir Alafenamide Fumarate Tablets Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Tenofovir Alafenamide Fumarate Tablets Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Tenofovir Alafenamide Fumarate Tablets Sales (K Units), 2018-2023
Table 15. By Type - Global Tenofovir Alafenamide Fumarate Tablets Sales (K Units), 2024-2029
Table 16. By Application – Global Tenofovir Alafenamide Fumarate Tablets Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Tenofovir Alafenamide Fumarate Tablets Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Tenofovir Alafenamide Fumarate Tablets Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Tenofovir Alafenamide Fumarate Tablets Sales (K Units), 2018-2023
Table 20. By Application - Global Tenofovir Alafenamide Fumarate Tablets Sales (K Units), 2024-2029
Table 21. By Region – Global Tenofovir Alafenamide Fumarate Tablets Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Tenofovir Alafenamide Fumarate Tablets Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Tenofovir Alafenamide Fumarate Tablets Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Tenofovir Alafenamide Fumarate Tablets Sales (K Units), 2018-2023
Table 25. By Region - Global Tenofovir Alafenamide Fumarate Tablets Sales (K Units), 2024-2029
Table 26. By Country - North America Tenofovir Alafenamide Fumarate Tablets Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Tenofovir Alafenamide Fumarate Tablets Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Tenofovir Alafenamide Fumarate Tablets Sales, (K Units), 2018-2023
Table 29. By Country - North America Tenofovir Alafenamide Fumarate Tablets Sales, (K Units), 2024-2029
Table 30. By Country - Europe Tenofovir Alafenamide Fumarate Tablets Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Tenofovir Alafenamide Fumarate Tablets Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Tenofovir Alafenamide Fumarate Tablets Sales, (K Units), 2018-2023
Table 33. By Country - Europe Tenofovir Alafenamide Fumarate Tablets Sales, (K Units), 2024-2029
Table 34. By Region - Asia Tenofovir Alafenamide Fumarate Tablets Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Tenofovir Alafenamide Fumarate Tablets Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Tenofovir Alafenamide Fumarate Tablets Sales, (K Units), 2018-2023
Table 37. By Region - Asia Tenofovir Alafenamide Fumarate Tablets Sales, (K Units), 2024-2029
Table 38. By Country - South America Tenofovir Alafenamide Fumarate Tablets Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Tenofovir Alafenamide Fumarate Tablets Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Tenofovir Alafenamide Fumarate Tablets Sales, (K Units), 2018-2023
Table 41. By Country - South America Tenofovir Alafenamide Fumarate Tablets Sales, (K Units), 2024-2029
Table 42. By Country - Middle East & Africa Tenofovir Alafenamide Fumarate Tablets Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Tenofovir Alafenamide Fumarate Tablets Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Tenofovir Alafenamide Fumarate Tablets Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa Tenofovir Alafenamide Fumarate Tablets Sales, (K Units), 2024-2029
Table 46. CSPC OUYI Pharmaceutical Co., Ltd. Company Summary
Table 47. CSPC OUYI Pharmaceutical Co., Ltd. Tenofovir Alafenamide Fumarate Tablets Product Offerings
Table 48. CSPC OUYI Pharmaceutical Co., Ltd. Tenofovir Alafenamide Fumarate Tablets Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 49. CSPC OUYI Pharmaceutical Co., Ltd. Key News & Latest Developments
Table 50. Gilead Sciences, Inc. Company Summary
Table 51. Gilead Sciences, Inc. Tenofovir Alafenamide Fumarate Tablets Product Offerings
Table 52. Gilead Sciences, Inc. Tenofovir Alafenamide Fumarate Tablets Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 53. Gilead Sciences, Inc. Key News & Latest Developments
Table 54. Yichang Humanwell Pharmaceutical Co., Ltd. Company Summary
Table 55. Yichang Humanwell Pharmaceutical Co., Ltd. Tenofovir Alafenamide Fumarate Tablets Product Offerings
Table 56. Yichang Humanwell Pharmaceutical Co., Ltd. Tenofovir Alafenamide Fumarate Tablets Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 57. Yichang Humanwell Pharmaceutical Co., Ltd. Key News & Latest Developments
Table 58. Shandong Loncom Pharmaceutical Co., Ltd Company Summary
Table 59. Shandong Loncom Pharmaceutical Co., Ltd Tenofovir Alafenamide Fumarate Tablets Product Offerings
Table 60. Shandong Loncom Pharmaceutical Co., Ltd Tenofovir Alafenamide Fumarate Tablets Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 61. Shandong Loncom Pharmaceutical Co., Ltd Key News & Latest Developments
Table 62. Reyoung Pharmaceutical Co., Ltd. Company Summary
Table 63. Reyoung Pharmaceutical Co., Ltd. Tenofovir Alafenamide Fumarate Tablets Product Offerings
Table 64. Reyoung Pharmaceutical Co., Ltd. Tenofovir Alafenamide Fumarate Tablets Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 65. Reyoung Pharmaceutical Co., Ltd. Key News & Latest Developments
Table 66. Suzhou Homesun Pharmaceutical Co.,Ltd. Company Summary
Table 67. Suzhou Homesun Pharmaceutical Co.,Ltd. Tenofovir Alafenamide Fumarate Tablets Product Offerings
Table 68. Suzhou Homesun Pharmaceutical Co.,Ltd. Tenofovir Alafenamide Fumarate Tablets Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 69. Suzhou Homesun Pharmaceutical Co.,Ltd. Key News & Latest Developments
Table 70. Hunan Mingrui Pharmaceutical Co., Ltd. Company Summary
Table 71. Hunan Mingrui Pharmaceutical Co., Ltd. Tenofovir Alafenamide Fumarate Tablets Product Offerings
Table 72. Hunan Mingrui Pharmaceutical Co., Ltd. Tenofovir Alafenamide Fumarate Tablets Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 73. Hunan Mingrui Pharmaceutical Co., Ltd. Key News & Latest Developments
Table 74. DESANO Company Summary
Table 75. DESANO Tenofovir Alafenamide Fumarate Tablets Product Offerings
Table 76. DESANO Tenofovir Alafenamide Fumarate Tablets Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 77. DESANO Key News & Latest Developments
Table 78. Patheon Inc. Company Summary
Table 79. Patheon Inc. Tenofovir Alafenamide Fumarate Tablets Product Offerings
Table 80. Patheon Inc. Tenofovir Alafenamide Fumarate Tablets Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 81. Patheon Inc. Key News & Latest Developments
Table 82. Suzhou Thery Pharmaceutical Inc. Company Summary
Table 83. Suzhou Thery Pharmaceutical Inc. Tenofovir Alafenamide Fumarate Tablets Product Offerings
Table 84. Suzhou Thery Pharmaceutical Inc. Tenofovir Alafenamide Fumarate Tablets Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 85. Suzhou Thery Pharmaceutical Inc. Key News & Latest Developments
Table 86. Chengdu Easton Biopharmaceuticals Co.,Ltd. Company Summary
Table 87. Chengdu Easton Biopharmaceuticals Co.,Ltd. Tenofovir Alafenamide Fumarate Tablets Product Offerings
Table 88. Chengdu Easton Biopharmaceuticals Co.,Ltd. Tenofovir Alafenamide Fumarate Tablets Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 89. Chengdu Easton Biopharmaceuticals Co.,Ltd. Key News & Latest Developments
Table 90. Tenofovir Alafenamide Fumarate Tablets Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2023 (K Units)
Table 91. Global Tenofovir Alafenamide Fumarate Tablets Capacity Market Share of Key Manufacturers, 2021-2023
Table 92. Global Tenofovir Alafenamide Fumarate Tablets Production by Region, 2018-2023 (K Units)
Table 93. Global Tenofovir Alafenamide Fumarate Tablets Production by Region, 2024-2029 (K Units)
Table 94. Tenofovir Alafenamide Fumarate Tablets Market Opportunities & Trends in Global Market
Table 95. Tenofovir Alafenamide Fumarate Tablets Market Drivers in Global Market
Table 96. Tenofovir Alafenamide Fumarate Tablets Market Restraints in Global Market
Table 97. Tenofovir Alafenamide Fumarate Tablets Raw Materials
Table 98. Tenofovir Alafenamide Fumarate Tablets Raw Materials Suppliers in Global Market
Table 99. Typical Tenofovir Alafenamide Fumarate Tablets Downstream
Table 100. Tenofovir Alafenamide Fumarate Tablets Downstream Clients in Global Market
Table 101. Tenofovir Alafenamide Fumarate Tablets Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Tenofovir Alafenamide Fumarate Tablets Segment by Type in 2022
Figure 2. Tenofovir Alafenamide Fumarate Tablets Segment by Application in 2022
Figure 3. Global Tenofovir Alafenamide Fumarate Tablets Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Tenofovir Alafenamide Fumarate Tablets Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Tenofovir Alafenamide Fumarate Tablets Revenue, 2018-2029 (US$, Mn)
Figure 7. Tenofovir Alafenamide Fumarate Tablets Sales in Global Market: 2018-2029 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Tenofovir Alafenamide Fumarate Tablets Revenue in 2022
Figure 9. By Type - Global Tenofovir Alafenamide Fumarate Tablets Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Tenofovir Alafenamide Fumarate Tablets Revenue Market Share, 2018-2029
Figure 11. By Type - Global Tenofovir Alafenamide Fumarate Tablets Sales Market Share, 2018-2029
Figure 12. By Type - Global Tenofovir Alafenamide Fumarate Tablets Price (US$/Unit), 2018-2029
Figure 13. By Application - Global Tenofovir Alafenamide Fumarate Tablets Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Tenofovir Alafenamide Fumarate Tablets Revenue Market Share, 2018-2029
Figure 15. By Application - Global Tenofovir Alafenamide Fumarate Tablets Sales Market Share, 2018-2029
Figure 16. By Application - Global Tenofovir Alafenamide Fumarate Tablets Price (US$/Unit), 2018-2029
Figure 17. By Region - Global Tenofovir Alafenamide Fumarate Tablets Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Tenofovir Alafenamide Fumarate Tablets Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Tenofovir Alafenamide Fumarate Tablets Revenue Market Share, 2018-2029
Figure 20. By Region - Global Tenofovir Alafenamide Fumarate Tablets Sales Market Share, 2018-2029
Figure 21. By Country - North America Tenofovir Alafenamide Fumarate Tablets Revenue Market Share, 2018-2029
Figure 22. By Country - North America Tenofovir Alafenamide Fumarate Tablets Sales Market Share, 2018-2029
Figure 23. US Tenofovir Alafenamide Fumarate Tablets Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Tenofovir Alafenamide Fumarate Tablets Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Tenofovir Alafenamide Fumarate Tablets Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Tenofovir Alafenamide Fumarate Tablets Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Tenofovir Alafenamide Fumarate Tablets Sales Market Share, 2018-2029
Figure 28. Germany Tenofovir Alafenamide Fumarate Tablets Revenue, (US$, Mn), 2018-2029
Figure 29. France Tenofovir Alafenamide Fumarate Tablets Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Tenofovir Alafenamide Fumarate Tablets Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Tenofovir Alafenamide Fumarate Tablets Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Tenofovir Alafenamide Fumarate Tablets Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Tenofovir Alafenamide Fumarate Tablets Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Tenofovir Alafenamide Fumarate Tablets Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Tenofovir Alafenamide Fumarate Tablets Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Tenofovir Alafenamide Fumarate Tablets Sales Market Share, 2018-2029
Figure 37. China Tenofovir Alafenamide Fumarate Tablets Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Tenofovir Alafenamide Fumarate Tablets Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Tenofovir Alafenamide Fumarate Tablets Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Tenofovir Alafenamide Fumarate Tablets Revenue, (US$, Mn), 2018-2029
Figure 41. India Tenofovir Alafenamide Fumarate Tablets Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Tenofovir Alafenamide Fumarate Tablets Revenue Market Share, 2018-2029
Figure 43. By Country - South America Tenofovir Alafenamide Fumarate Tablets Sales Market Share, 2018-2029
Figure 44. Brazil Tenofovir Alafenamide Fumarate Tablets Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Tenofovir Alafenamide Fumarate Tablets Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Tenofovir Alafenamide Fumarate Tablets Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Tenofovir Alafenamide Fumarate Tablets Sales Market Share, 2018-2029
Figure 48. Turkey Tenofovir Alafenamide Fumarate Tablets Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Tenofovir Alafenamide Fumarate Tablets Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Tenofovir Alafenamide Fumarate Tablets Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Tenofovir Alafenamide Fumarate Tablets Revenue, (US$, Mn), 2018-2029
Figure 52. Global Tenofovir Alafenamide Fumarate Tablets Production Capacity (K Units), 2018-2029
Figure 53. The Percentage of Production Tenofovir Alafenamide Fumarate Tablets by Region, 2022 VS 2029
Figure 54. Tenofovir Alafenamide Fumarate Tablets Industry Value Chain
Figure 55. Marketing Channels

【テノフォビルアラフェナミドフマル酸塩錠剤について】 テノフォビルアラフェナミドフマル酸塩錠剤は、抗ウイルス薬として使用される医薬品の一つであり、特にHIV（ヒト免疫不全ウイルス）感染症やB型肝炎ウイルスの治療に用いられます。この薬はテノフォビルの新しい形態であり、より優れた効果を発揮することが期待されています。テノフォビルアラフェナミド（Tenofovir Alafenamide、TAF）は、従来のテノフォビル（Tenofovir disoproxil fumarate、TDF）と比較して、細胞内での活性化が効率的であるため、より低い用量での投与が可能です。これにより、腎臓や骨密度に対する副作用のリスクを軽減することができます。 テノフォビルアラフェナミドの特徴として、まずその構造的な特性が挙げられます。TAFは、脂溶性が高いため、細胞膜を通過しやすく、ヒトの体内において迅速に活性化されることができます。このため、従来のテノフォビルよりも少ない用量で効果を示すことができ、その結果、副作用のリスクが低減されます。また、TAFはHIVやHBVに対して強力な抗ウイルス作用を示すことから、これらのウイルスに感染している患者において効果的な治療法として位置づけられています。 この薬は、通常、1日1回の服用が推奨されており、食事とともに摂取することで吸収率が向上します。医療機関では、テノフォビルアラフェナミドを含む抗レトロウイルス療法（ART）がHIV感染者の治療に使用され、ウイルス量を抑制し、免疫系を保護するための重要な手段とされています。薬物治療が適切に行われることで、HIV感染者の生活の質は大きく向上し、長期的な健康状態が改善される可能性があります。 テノフォビルアラフェナミドは、HIV感染者に対する単剤療法だけでなく、複数の抗ウイルス薬と併用する治療法においても使用されることがあります。この場合、薬剤の相互作用や副作用のリスクを考慮しながら、医師が適切な治療法を選択します。併用療法は、HIVウイルスの耐性を防ぐためにも重要です。ウイルスが薬に対して耐性を獲得することを防ぐため、異なる作用機序を持つ薬剤を組み合わせることがしばしば行われます。 テノフォビルアラフェナミドは、またHBV（B型肝炎ウイルス）に対する治療にも使用されます。B型肝炎の治療において、TAFはウイルスの複製を抑制し、肝機能を改善する効果があります。HBV感染による肝炎の進行は深刻な問題であり、肝硬変や肝癌のリスクを増加させることがあります。そのため、TAFの使用は、これらの合併症を予防する手段となります。 関連技術としては、テノフォビルアラフェナミドが開発された背景には、より効果的かつ安全な治療法を求めるニーズがあります。アメリカ合衆国食品医薬品局（FDA）がこの薬を承認したのは、臨床試験においてTAFが高い効果と良好な安全性を示したことが大きな要因です。これらの試験では、テノフォビルアラフェナミドを投与された患者において、ウイルス量の有意な低下や副作用の少なさが確認されています。 一方で、テノフォビルアラフェナミドを使用する際には、いくつかの注意点や副作用が存在します。一般的な副作用には、吐き気、下痢、疲労感、腹痛などが含まれます。また、稀に腎機能に影響を与えることがあるため、定期的な血液検査が推奨されることがあります。特に、既存の腎疾患を持つ患者には注意が必要です。そのため、治療前には医師が患者の状態を十分に評価し、適切な監視を行うことが重要です。 テノフォビルアラフェナミドは、感染症の治療において重要な役割を果たす薬剤であり、HIV感染者やB型肝炎の患者にとって、治療の選択肢を広げるものとなっています。ただし、薬剤の効果を最大限に引き出すためには、医師の指導のもとで適切に使用し、定期的なフォローアップを行うことが必要です。今後もこの薬剤に関する研究は続けられ、新たな知見が得られることが期待されています。科学の進歩によって、より多くの患者が恩恵を受ける日が来ることを願ってやみません。